Tag: H.C. Wainwright
-
This is Why Cassava Sciences (SAVA) Could Explode — Again
Cassava Sciences (SAVA) is soaring again. After pulling back to strong support around $91, the stock is back to $108 thanks to new price targets, and progress on its lead drug candidate for Alzheimer’s. H.C. Wainwright raised its price target to $124 on SAVA. Cantor Fitzgerald raised its target to $100. Better, the company already…